|
2015
|
Invention
|
Inhibitors of polo-like kinase.
The present invention provides compounds having a structure acco... |
|
2013
|
Invention
|
Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds.
Dis... |
|
|
Invention
|
Spirocyclic dihydro-thiazine and dihydro-oxazine bace inhibitors, and compositions and uses there... |
|
|
Invention
|
Multimeric vla-4 antagonists comprising polymers moieties.
Disclosed are conjugates which bind V... |
|
|
Invention
|
Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds.
Alph... |
|
2012
|
Invention
|
Pyridinone antagonists of alpha-4 integrins.
The present invention provides compounds that are a... |
|
|
Invention
|
Combination treatments for bipolar disorders.
The invention relates generally to novel compositi... |
|
|
Invention
|
Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds. Disc... |
|
|
Invention
|
Therapeutic uses of humanized antibodies against alpha-4 integrin.
The invention provides method... |
|
|
Invention
|
Methods of treating behavioral and psychiatric disorders.
The invention relates to the treatment... |
|
|
Invention
|
Scyllo-inositol for the treatment of behavioral and psychiatric disorders. The invention relates ... |
|
|
Invention
|
Cinnoline compounds as inhibitor of lrrk2 kinase activity. The present invention provides compoun... |
|
|
Invention
|
Inhibitors of lrrk2 kinase activity. The present invention provides compounds having a structure ... |
|
|
Invention
|
Prevention and treatment of synucleinopathic and amyloidogenic disease.
The invention provides i... |
|
|
Invention
|
N-substituted benzene sulfonamides.
The invention provides N-substituted benzenesulfonamides for... |
|
|
Invention
|
Apoe immunotherapy.
The present invention provides antibodies that preferentially bind to an Apo... |
|
2011
|
Invention
|
Phagocytic activity as a marker of synucleinopathic disease.
The invention provides methods of s... |
|
|
Invention
|
Phagocytic activity as a marker of synucleinopathic disease. The invention provides methods of sc... |
|
|
Invention
|
Methods for determining differences in alpha-4 integrin activity by correlating differences in sv... |
|
|
Invention
|
Methods of synthesis of scyllitol and related compounds. Methods of synthesis of scyllitol dibora... |
|
|
Invention
|
Inhibitors of polo-like kinase. The present invention provides compounds having a structure accor... |
|
|
Invention
|
Alzheimer's disease secretase, app substrates therefor, and uses therefor.
The present invention... |
|
|
Invention
|
Selective integrin inhibitors. This invention provides methods for selectively antagonizing the a... |
|
|
Invention
|
Selective integrin inhibitors. This invention provides methods for selectively antagonizing the α... |
|
|
Invention
|
Prevention and treatment of amyloidogenic diseases.
Active immunotherapy methods for treating a ... |
|
|
Invention
|
Beta-secretase enzyme compositions and methods.
Disclosed are various forms of an active, isolat... |
|
|
Invention
|
Compositions and methods for identifying substrate specificity of inhibitors of gamma secretase. ... |
|
|
Invention
|
Prevention and treatment of amyloidogenic diseases.
Passive immunotherapy methods for treating a... |
|
|
Invention
|
Use of perlecan domain v in treating amyloidogenic disease. The application reports that perlecan... |
|
2010
|
Invention
|
Pteridinones as inhibitors of polo-like kinase. The present invention provides compounds having a... |
|
|
Invention
|
Pteridinones as inhibitors of polo - like kinase. The present invention provides compounds having... |
|
|
Invention
|
Prevention and treatment of amyloidogenic disease.
Disclosed are pharmaceutical compositions and... |
|
|
Invention
|
Multimeric vla-4 antagonists comprising polymer moieties. Disclosed are conjugates exhibiting VLA... |
|
|
Invention
|
Bridged n-cyclic sulfonamido inhibitors of gamma secretase.
The invention provides N-cyclic sulf... |
|
|
Invention
|
Pyridinone antagonists of alpha-4 integrins. The present invention provides compounds that are al... |
|
|
Invention
|
Process for the production of fused, tricyclic sulfonamides.
The present invention provides meth... |
|
|
Invention
|
Signaling intermediates in an in vitro model of alzheimer's disease.
The invention provides a no... |
|
2008
|
Invention
|
Ligand screening method using a crystal of beta secretase. The x-ray crystal structure of BACE or... |
|
2006
|
Invention
|
Bridged n-bicyclic sulfonamido inhibitors of gamma secretase.
The invention provides N-bicyclic ... |
|
|
Invention
|
Genomic alpha synuclein transgenic animal. The invention provides transgenic animals having a tra... |
|
1995
|
G/S
|
Diagnostic and prognostic clinical testing services. |
|
1994
|
G/S
|
Pharmacy services. |
|
1993
|
G/S
|
Pharmaceutical preparations for the treatment of diseases affecting the central nervous system. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of diseases affecting the central nervous system an... |
